论文部分内容阅读
Introduction: Through psychological autopsies it has been estimated that more than 90% of people who commit suicide have a diagnosable psychological disturbance at the time of death, being Schizophrenia one of the most frequently found after depression.In fact, these patients have a risk of about 10% of committing suicide, a value much higher when compared to the general population, being suicide the first cause of premature death in these patients.In this way its of the outmost urgency not only to diagnose risk patients, has well has to develop effective preventive and therapeutically strategies.Objective: The aim of this revision work was to come to acquaintance with the reality of suicidal behaviours in patients with schizophrenia, specifically systematize in a broad way the multiple risk factors involved and their correlations.It was also a goal of this study to acknowledge the current status of the several facets of a wide and multidisciplinary therapeutic approach, in the sense of preventing suicidal behaviours of schizophrenic patients.Methods: It was made a bibliographic research, essentially through the data base PubMed, emphasizing the present and importance of information present in multiple publications.It was also gathered information present in some works of several authors who have been dedicated to the thematic of suicide in schizophrenic patients.Results: In what concerns suicidal conducts in schizophrenic patients, there are identified today several risk factors: male, weak social network support, high levels of pre-morbid behaviour, first years after diagnose, adverse life events, previous suicidal attempts, co-morbid affective disturbances and/or specific affective symptoms, particularly hopelessness, substance abuse and recent medical discharge without an adequate treatment planning.There are some controversial questions regarding the influence of psychotic symptoms, as well as the presence of critical judgment by patients themselves.Regarding the therapeutic approach, recent data has demonstrated that the use of untypical antipsychotics on the treatment of schizophrenia, presents better results when compared to common neuroleptics.It has been demonstrated they prevent suicidal attempts, they show more anti-depressive efficiency, they decrease the probability of side effects and they improve cognitive functions.Clozapine is the antipsychotic with better results in these patients being advised its use in schizophrenic patients with high risk of suicide.However, the best therapeutic approach includes the combination of pharmacotherapy with psychotherapy and optimization of modifiable risk factors, being so, that together they have been showing greater efficiency in preventing and treating suicidal behaviours when comparing each method on its own.Conclusion: In spite of the existence of a wide amount of information available which helps health care professionals in better understanding suicidal conducts in the schizophrenic patient, it remains some controversial aspects that deserve a better clarification with the purpose of helping optimize the health care to these patients.It is of the outmost importance to develop and put in practice in a broad way, plans of suicidal prevention in schizophrenic patients.So, it is necessary an adequate and complete multidisciplinary approach involving patients, doctors, nursing teams, psychotherapists, families and the society in general.